Treasury Board of Canada Secretariat
www.tbs-sct.gc.ca
Common menu bar links
Breadcrumb Trail
ARCHIVED - Patented Medicine Prices Review Board Canada
This page has been archived.
Archived Content
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
SECTION III – SUPPLEMENTARY INFORMATION
Table 1: Departmental links to the Government of Canada Outcomes
| Strategic Outcome: Canadians and their health care system are protected from excessive pricing for patented medicines sold in Canada and are informed on pharmaceutical trends. | |||||
| Program Activity | Expected Results |
Planned Spending ($ thousands) |
Alignment to Government of Canada Outcome Area | ||
| 2008-2009 | 2009-2010 | 2010-2011 | |||
| Compliance and enforcement of non-excessive pricing for patented medicines | Prices charged by patentees for patented medicines in Canada are not excessive according to the factors of the Patent Act. | 3,194.0 | 3,194.0 | 3,194.0 | Healthy Canadians |
| Pharmaceutical trends | Stakeholders are more aware of pharmaceutical trends and cost drivers. | 2,648.0 | 2,648.0 | 2,648.0 | Healthy Canadians |
Tables available electronically at: http://www.tbs-sct.gc.ca/rpp/2008-2009/info/info-eng.asp
Table 2: Services Received Without Charge
Table 3: Sources of Non-respendable Revenue
1 The money reported as non-respendable revenue does not represent revenues generated by the PMPRB. This money is a result of payments made by patentees to the Government of Canada through Voluntary Compliance Undertakings (VCUs) or Board Orders to offset excess revenues. The Minister may enter into agreements with any province or territory respecting the distribution to provinces and territories of amounts received by the Receiver General from recovered excess revenues, less any costs incurred in relation to the collection and distribution of those amounts.
2 Services provided without charge are for: accommodation provided by Public Works and Government Services Canada; contributions covering employer’s share of employees’ insurance premiums and expenditures paid by the Treasury Board of Canada Secretariat; and Salary and associated expenditures of legal services provided by the Department of Justice Canada.
3The PMPRB has no authority to regulate the prices of non-patented drugs, and does not have jurisdiction over prices charged by wholesalers or retailers, or over pharmacists’ professional fees. Also, matters such as whether medicines are reimbursed by public drug plans and prescribing are outside the purview of the PMPRB.
4 Additional information on the Guidelines c an be found in Chapter 1 of the Compendium of Guidelines, Policies and Procedures which is available on the PMPRB Web site : www.pmprb-cepmb.gc.ca , under Legislation, Regulations, Guidelines.
5 Additional information on the criteria
for commencing an investigation can be found in Schedule 5 of the Compendium
of Guidelines, Policies and Procedures which is available on the PMPRB Web
site:
www.pmprb-cepmb.gc.ca , under
Legislation, Regulations, Guidelines.
6 Class of customer: pharmacies, hospitals, wholesalers, others.
